1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Brenner Tumor Global Clinical Trials Review, H1, 2016

Brenner Tumor Global Clinical Trials Review, H1, 2016

  • June 2016
  • -
  • Global Data
  • -
  • 67 pages

Brenner Tumor Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2016" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner Tumor. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Brenner Tumor Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Brenner Tumor to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Brenner Tumor to Oncology Clinical Trials 15
Clinical Trials in E7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Brenner Tumor Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 67

List of Tables
Brenner Tumor Therapeutics, Global, Clinical Trials by Region, 2016* 5
Brenner Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Brenner Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Brenner Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 8
Brenner Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Brenner Tumor Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Brenner Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Proportion of Brenner Tumor to Oncology Clinical Trials, G7 Countries (%), 2016* 12
Brenner Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Brenner Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Brenner Tumor to Oncology Clinical Trials, E7 Countries (%), 2016* 15
Brenner Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16
Brenner Tumor Therapeutics, Global, Clinical Trials by Phase, 2016* 17
Brenner Tumor Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18
Brenner Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Brenner Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Brenner Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Brenner Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22
Brenner Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Brenner Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Brenner Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25

List of Figures
Brenner Tumor Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Brenner Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Brenner Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Brenner Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 8
Brenner Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
Brenner Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Proportion of Brenner Tumor to Oncology Clinical Trials, G7 Countries (%), 2016* 12
Brenner Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Brenner Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Brenner Tumor to Oncology Clinical Trials, E7 Countries (%), 2016* 15
Brenner Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16
Brenner Tumor Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17
Brenner Tumor Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18
Brenner Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Brenner Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Brenner Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Brenner Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22
Brenner Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Brenner Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Brenner Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
GlobalData Methodology 65

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016 - 2026

Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016 - 2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cervical Cancer in 22 Major Markets Cervical cancer (ICD-10 code C53, cervix uteri) is a type of cancer that occurs in the cells of ...

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025

  • $ 4995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.